This commentary examines a multicenter randomized controlled trial that evaluated the efficacy of acupuncture on ischemic stroke recovery.[@bib0060]

1. Focal article {#sec0005}
================
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2. Aim {#sec0010}
======

Studies concerning the efficacy of acupuncture for stroke recovery have been criticized because of methodological weaknesses. The purpose of this study was to assess the efficacy of acupuncture in ischemic stroke recovery using an advanced clinical trial design.

3. Design {#sec0015}
=========

This was a multicenter, single-blinded, randomized controlled trial.

4. Setting {#sec0020}
==========

The study was divided into two phases, namely, a pilot study conducted from April 2001 to February 2002, and a main study conducted from February 2002 to February 2004. The study was registered with the Chinese Clinical Trial Register (ChiCTR-TRC-11001353). The study protocol was approved by the West China Hospital of Sichuan University Ethics Committee. Hospitalized patients with limb paralysis (*n* = 862) were enrolled in this study.

5. Participants {#sec0025}
===============

Male and female acute ischemic stroke patients aged 18--85 years were eligible for this study. The World Health Organization stroke criteria were used to confirm diagnoses. Computed tomography and magnetic resonance imaging were performed to exclude intracerebral hemorrhage. Only patients with limbs paralysis that prevented walking, eating, or dressing without assistance were included.

6. Study exclusion criteria {#sec0030}
===========================

Exclusion criteria were as follows: (1) dependency in activities of daily living (ADLs) before the stroke episode; (2) inability to complete the treatment course, (3) infection at acupuncture sites; (4) severe aphasia or unconsciousness, making it difficult to comprehend the study or cooperate with evaluation; and (5) other complications/comorbidities such as heart/renal failure.

7. Intervention {#sec0035}
===============

Both treatment and control groups received routine stroke treatment and rehabilitation. The treatment group (*n* = 427) received standard care plus acupuncture. For patients in this group, Chinese acupuncture was administered 3--10 days after stroke onset, 5 times/wk, for 3 weeks. The acupoints included Renzhong (DU26), Neiguan (PC6, both sides), and Sanyinjiao (SP6, paretic side). Auxiliary acupoints included Baihui (DU20), four acupoints on the paretic side (Zusanli-ST36, Fenglong-ST40, Taichong-LK3, and Chize-LL5), and two acupoints (Fengchi-GB20 and Qihai-RN6) needled on both sides. Huato sterile acupuncture needles (1.5--4 cm in length and 0.38--0.42 mm in diameter) were used. The control group (*n* = 435) received standard care only.

8. Main outcome measures {#sec0040}
========================

Neurological deficits and ADLs were evaluated by blinded investigators. A subgroup analysis compared patients receiving 10 or more acupuncture sessions with the control group.

8.1. Severity of neurological deficit {#sec0045}
-------------------------------------

The Scandinavian Stroke Scale (SSS) score was measured at baseline, at the end of treatment, or at discharge. The SSS includes 10 items with a total score of 0--60 points, with higher scores indicating better neurological function.

8.2. Barthel Index {#sec0050}
------------------

The ADLs were assessed using the Barthel Index (BI), which includes 10 personal activities with a maximum score of 100 points. A higher score indicates better function.

*Primary outcomes* were as follows: (1) Death/disability at 6 months (disability was defined as a BI ≤ 60 points). (2) Death/long-term institutional care at 6 months.

*Secondary outcomes* were as follows: (1) Changes in the neurological deficit score at the end of treatment or at discharge. (2) Fatality.

9. Main results {#sec0055}
===============

At 6 months, 40 (9.4%) patients in the acupuncture group and 39 (9.0%) in the control group were lost to follow up. The intention-to-treat principle was applied for the statistical analysis.

9.1. Death/disability {#sec0060}
---------------------

Compared with control patients, fewer acupuncture patients died or were dependent in ADL at 3 months (113/410, 27.6% vs. 137/405, 33%) and 6 months (80/385, 20.7% vs. 102/396, 25.8%), respectively, however, the differences were not statistically different. The odds ratio (OR) was 0.77 \[95% confidence interval (CI) 0.57--1.04\] at 3 months, and 0.75 (95% CI 0.54--1.05) at 6 months. Patients who received 10 or more acupuncture sessions were included in the subgroup analysis; a significant difference was detected only at 6 months (57/298, 19.1% vs. 102/396, 25.8%). The OR was 0.68 (95% CI 0.47--0.98).

9.2. Death/institutional care {#sec0065}
-----------------------------

There were no statistical differences at 3 months (38/410, 8.5% vs. 41/405, 9.9%) and 6 months (31/387, 8.0% vs. 30/396, 7.6%) between the acupuncture and control groups, respectively.

9.3. Changes in the neurological deficit score (SSS) from baseline {#sec0070}
------------------------------------------------------------------

A significantly greater change was observed in the acupuncture group, compared with the control group (9.70 ± 7.85 vs. 7.57 ± 12.58; *p* = 0.03).

9.4. Adverse events {#sec0075}
-------------------

Severe adverse events occurred in 7.6% and 8.3% of the patients in the acupuncture and control groups, respectively. The most common acupuncture-related adverse event was moderate to severe pain (9.4%); 1.9% of the patients discontinued acupuncture treatment due to pain.

10. Authors' conclusions {#sec0080}
========================

This study in focus assessed the efficacy of acupuncture as an adjunct to standard care in the early stages of stroke. The results did not support its use. However, fewer patients showed dependency in the acupuncture group, especially those who had received 10 or more acupuncture treatments. Large-scale trials are therefore needed to confirm the potential benefits of acupuncture for poststroke rehabilitation.
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13. Comment/Critique {#sec0095}
====================

Acupuncture has been used in traditional Asian medicine to treat stroke for over 1,000 years. Many Chinese clinical trials that have shown the effect of acupuncture in stroke patients have been criticized because of small sample sizes and methodological weaknesses. This study overcomes several methodological problems such as using outcomes that are not internationally recognized, unclear methods of randomization and allocation concealment, lack of long-term follow up, and publication bias.

In this study, acupuncture was not effective in reducing mortality, dependency, or institutional care. However, greater improvements in neurological deficits were observed. In the subgroup analysis, patients who received 10 or more acupuncture sessions had lower mortality and less dependency. The results were consistent with three recently published studies and two systematic poststroke rehabilitation reviews.[@bib0065], [@bib0070], [@bib0075], [@bib0080], [@bib0085] In the study by Sze et al[@bib0070], 106 stroke patients were divided into two groups. The acupuncture group received 35 acupuncture sessions over 10 weeks using 10 main acupoints. The control group received the standard treatment. A blinded assessor evaluated the patients at 0 weeks, 5 weeks, and 10 weeks using the Fugl-Meyer assessment, BI, and the functional independence measure. No significant differences were observed between the two groups. Park et al[@bib0075] offered 12 acupuncture sessions to 116 recent stroke patients (\<4 weeks) for 2 weeks and compared the effects of real and sham acupuncture. The BI, National Institute of Health Stroke Scale, and quality of life (EQ-5D) scores were not significantly different between the groups. Hopwood et al[@bib0080] treated patients between 4 days and 10 days after the first stroke episode. The treatment group received real acupuncture and electrostimulation; the control group received sham electrostimulation. There were no significant differences in the BI between the groups.

A systematic review published in 2010 in *Stroke* included 56 randomized controlled trials published before 2009.[@bib0085] None of the trials conducted outside of China reported positive results, whereas all of the Chinese trials except for one showed positive results. Thirty-five studies conducted in China reported an OR of 4.49 (95% CI 3.16--6.39); three studies conducted elsewhere reported an OR of 3.33 (95% CI 0.75--14.88).

Another interesting aspect of this study is that the authors merged their data with a previous meta-analysis (Cochrane\'s systematic review of acupuncture for stroke).[@bib0065] In that review, death and dependency in 373 patients from four trials were assessed (V. Hopwood, personal communication, 2003).[@bib0090], [@bib0095], [@bib0115] There were borderline significant differences in mortality and dependency between the treatment and control groups (OR 0.66, 95% CI 0.43--0.99). The authors merged their data with the review data with improved results (OR 0.72 95% CI 0.55--0.93). They argued that the merged data suggest that the results of this trial were not significantly different because the trial was still underpowered, and that the merged data suggest that acupuncture might reduce death or disabilities; however, larger trials are needed to confirm this viewpoint. There are few interventions in acute/subacute stroke patients that decrease the absolute risk by \>10%, except when using recombinant tissue-type plasminogen activator treatment.

This study overcomes several limitations of previous acupuncture research for stroke patients. It is the largest research study undertaken to date. Most Chinese studies have been criticized because of allocation concealment, the randomization process, short-term follow up, and blinding assessment. This study overcame such problems. In Cochrane\'s review, the primary outcomes at follow up were: (1) death or dependency; (2) death or a requirement for institutional care; or (3) adverse event.[@bib0065] Not many acupuncture stroke studies have adopted disability, ADL, or death as outcome measures, however, this study used the same outcomes as in the Cochrane review.

Unlike previous stroke research, the authors used a binary primary outcome measure. A systematic review compared placebo with no treatment for various diseases.[@bib0100] In the binary outcome, the placebo had no significant effect regardless of the subjective or objective outcomes. However, in the subjective continuous outcome, the pooled standard mean difference was significantly different from no treatment. In another pain study, Moore et al[@bib0105] investigated whether the binary outcome is more informative in interpreting drug efficacy. They concluded that responder analysis might be more sensitive than the average change in continuous visual analog scale pain scores. In another study, Moore et al[@bib0110] stated that the group mean effect may not accurately reflect individual responses and the clinical meaning is difficult to interpret. Using the binary outcome might be a solution in acupuncture research if real and sham acupuncture are not statistically different in terms of efficacy.

In my opinion, merging previous meta-analysis data and using the binary outcome is an interesting idea for acupuncture research that can also be applied to other research in integrative medicine.
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